Background: Clinical management of patients with congenital adrenal hyperplasia (CAH)
involves treating hormonal deficiencies, addressing issues related to genital ambiguity …

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that leads to the
partial or complete deficiency of cortisol and aldosterone production from the adrenal …

The surgical treatment of patients with congenital adrenal hyperplasia (CAH) has evolved
and improved over the past 3 decades since the authors have been caring for these …

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is characterized by
cortisol and in some cases aldosterone deficiency associated with androgen excess. Goals …

Abstract Treatment for congenital adrenal hyperplasia (CAH) was introduced in the 1950s
following the discovery of the structure and function of adrenocortical hormones. Although …

Congenital adrenal hyperplasia (CAH) is one of the most common autosomal recessive
disorders and is characterized by cortisol deficiency. The most common cause of CAH is a …

The treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is
complex. In addition to disease control, important therapeutic goals are the maintenance of …

Congenital adrenal hyperplasia (CAH) caused by 21‐hydroxylase deficiency accounts for
95% of all CAH cases and is one of the most common inborn metabolic conditions. The …

Abstract Congenital Adrenal Hyperplasia (CAH) is an inherited disorder due to mutations in
coding genes for enzymes involved in the production of adrenal hormones. The term …

The article presents opinion of the author on the prevalence of Congenital Adrenal
Hyperplasia (CAH) due to 21-hydroxylase deficiency. Topics discussed include guidelines …